摘要
绿脓杆菌是囊性纤维化患者中最常见的与院内感染和威胁生命的慢性感染有关的格兰性阴性菌。这些病原菌能够依附在医疗设备上形成细胞膜,包括规则排列的胞外聚合物。因其强烈地依附在设备的表面以及抗生素治疗固有的弹性,P.aeruginosa对临床药物产生一种比较严重地威胁,并且促进了慢性感染的长久性。在过去的十年微生物膜的研究主要包括在生物膜形成、耐药性和分散中环境信号、基因元素和分子机制的理解。从这些机制的研究中获得的信息对建立根治方法或阻止生物膜的形成很重要。目前,生物膜感染通常由抗生素和外科手术移除,此外被感染设备的频繁更换。此外近期鉴定的特殊的天然资源可作为康生物膜剂来抵抗病原菌。本文将强调近期抵抗体内和体外模型P.aerugunosa生物膜感染的植物源化合物的进展。
关键词: 康生物膜剂,绿脓杆菌,植物化学成分
图形摘要
Current Drug Targets
Title:Plant-derived Compounds as Potential Source of Novel Anti-Biofilm Agents Against Pseudomonas aeruginosa
Volume: 18 Issue: 4
关键词: 康生物膜剂,绿脓杆菌,植物化学成分
摘要: Pseudomonas aeruginosa is the most common Gram-negative bacterium associated with nosocomial and life-threatening chronic infections in cystic fibrosis patients. This pathogen is wellknown for its ability to attach to surfaces of indwelling medical devices to form biofilms, which consist of a regular array of extracellular polymers. Tenaciously bound to the surface of devices and inherently resilient to antibiotic treatment, P. aeruginosa poses a serious threat in clinical medicine and contributes to the persistence of chronic infections. Studies on microbial biofilms in the past decade involved mainly the understanding of environment signals, genetic elements and molecular mechanisms in biofilm formation, tolerance and dispersal. The knowledge obtained from the studies of these mechanisms is crucial in the establishment of strategies to eradicate or to prevent biofilm formation. Currently, biofilm infections are usually treated with combinations of antibiotics and surgical removal, in addition to frequent replacement of the infected device. More recently, specific natural sources have been identified as antibiofilm agents against this pathogen. This review will highlight the recent progress made by plant-derived compounds against P. aeruginosa biofilm infections in both in vitro or in vivo models.
Export Options
About this article
Cite this article as:
Plant-derived Compounds as Potential Source of Novel Anti-Biofilm Agents Against Pseudomonas aeruginosa, Current Drug Targets 2017; 18 (4) . https://dx.doi.org/10.2174/1389450117666161019102025
DOI https://dx.doi.org/10.2174/1389450117666161019102025 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Related Journals
Related Books
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Validity of Oxygen-Ozone Therapy as Integrated Medication Form in Chronic Inflammatory Diseases
Cardiovascular & Hematological Disorders-Drug Targets Pulmonary Hemorrhage in Patients with Systemic Lupus Erythematosus
Current Respiratory Medicine Reviews Atherogenic Index of Plasma in Women with Rheumatoid Arthritis and Systemic Lupus Erythematosus: A 10-Year Potential Predictor of Cardiovascular Disease
Current Rheumatology Reviews Therapeutic Agents for COVID-19: an Overview
Current Drug Therapy Prevention and Therapeutic Strategies of Thromboembolic Events in Patients with Inflammatory Bowel Diseases: A Report of Three Cases
Current Drug Targets Pharmacological Inhibitors of Cysteinyl Leukotrienes Biosynthesis: Therapeutic Implications
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents Management of Blood Pressure and Heart Rate in Acute Decompensated Heart Failure with Volume Overload
Current Pharmaceutical Design Use of Peripheral Blood Stem Cells in Tissue Engineering
Current Tissue Engineering (Discontinued) Mesenchymal Stem/Stromal Cells: A New "Cells as Drugs" Paradigm. Efficacy and Critical Aspects in Cell Therapy
Current Pharmaceutical Design Hyperhomocysteinemia and Endothelial Dysfunction
Current Hypertension Reviews Electrotransfer into Skeletal Muscle for Protein Expression
Current Gene Therapy Endogenous Chemical Mediators in Anti-Inflammation and Pro-Resolution
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents Treatment of Tachycardia in Hypertension: Where Do We Stand Now?
Current Hypertension Reviews Anesthesia Issues in Central Nervous System Disorders
Current Aging Science Contribution of Efflux Pump Activity to the Delivery of Pulmonary Therapeutics
Current Drug Metabolism Prevention of Respiratory Syncytial Virus: A Review
Current Respiratory Medicine Reviews Pulmonary and Nasal Anti-Inflammatory and Anti-Allergy Inhalation Aerosol Delivery Systems
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Neurovascular Complications of Ovarian Hyperstimulation Syndrome (OHSS): From Pathophysiology to Recent Treatment Options
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Current Therapeutic Strategies and Future Perspectives for the Prevention of Arterial Thromboembolism: Focus on Atrial Fibrillation
Current Pharmaceutical Design Benefits of L-Arginine on Cardiovascular System
Mini-Reviews in Medicinal Chemistry